syringe-1973129_960_720

Antibiotics found to fail in quarter of pneumonia patients

May 24, 2017
Research and Development Antibiotics, antibiotic resistance, pneumonia

A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …

merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017
Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …

scott_gottlieb

Opioid crisis “highest initial priority” for new FDA Commissioner

May 24, 2017
Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis

Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …

European approval for novel Eisai epilepsy monotherapy

May 23, 2017
Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy

Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …

2919193_kenneth

Nativis Incorporated appoints new CSO

May 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …

baking-soda-768950_960_720

Shortage of medicine made of kitchen basics hits US

May 23, 2017
Manufacturing and Production Pfizer, Sodium bicarbonate

Do you have a pot of unused baking soda that sits at the back of the cupboard, forgotten? Well, hospitals …

astrazeneca_plaque

Strong showing for AZ asthma drug, but diabetes treatment flops

May 23, 2017
Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes

AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …

theresa_may

U-turn performed over Conservative’s social care plans

May 23, 2017
Manufacturing and Production, Medical Communications Conservative, Dementia tax, Election 2017, Jeremy Corbyn, Labour, Theresa May

One of the most controversial points of the Conservative’s was its social care plan. The plan would have seen those …

Sanofi and Regeneron score FDA approval for arthritis

May 23, 2017
Manufacturing and Production, Sales and Marketing FDA, Kevzara, arthritis, sarilumab

The FDA has awarded Sanofi and Regeneron’s Kevzara (sarilumab) approval for the treatment of moderate to severely active rheumatoid arthritis …

sanofi_hq_reception_close

EMA’s CHMP recommends Sanofi’s Humalog biosimilar

May 22, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi

Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …

janeg

J&J lines up its Global Head for Actelion

May 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson

The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …

Behind the NHS recruitment crisis

May 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …

sanofi_new_paris_hq

Sanofi Zika vaccine deal causes controversy

May 22, 2017
Sales and Marketing Sanofi, US army, Zika

In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …

amgen_hq

Amgen hit by major safety blow on osteoporosis drug

May 22, 2017
Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …

70 patients sue Pfizer over arthritis drug risks

May 22, 2017
Sales and Marketing Pfizer, celebrex

Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …

astrazeneca_logo_building

AstraZeneca sells off rights to beta-blocker for $300 million

May 22, 2017
Sales and Marketing AstraZeneca, Recordati, Seloken

AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …

melanoma

No causal link between Viagra use and melanoma, study finds

May 19, 2017
Medical Communications, Research and Development melanoma, viagra

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …

abbviehqe_011_low

AbbVie suffers knock to Humira patent

May 19, 2017
Medical Communications, Sales and Marketing AbbVie, Humira, patents

Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …

The Gateway to Local Adoption Series

Latest content